Humans vary markedly in their propensity to develop asthma, despite often being exposed to similar environmental stimuli. Similarly, mouse strains vary in susceptibility to airways pathology in experimental asthma. Sensitization and aerosol challenge with ovalbumin (OVA) induces eosinophil accumulation, mucus production and airways obstruction in BALB/c and C57BL/6 mice. In contrast, CBA/Ca mice show relatively little pathology. Allergen-induced production of IL-4, IL-5, IL-10 and IFN-g was detected in all three strains, with BALB/c mice generating the highest levels of IL-4, IL-5 and IL-10. Microarray analysis was used to identify genes differentially regulated in lung tissue after OVA challenge. Differentially regulated genes in the lungs of the asthma-susceptible C57BL/6 and BALB/c strains numbered 242 and 145, respectively, whereas only 42 genes were differentially expressed in the resistant CBA/Ca strain. In C57BL/6 mice, transcripts were enriched for adhesion molecules and this was associated with high levels of eosinophil recruitment. Differentially regulated genes in the lungs of only the asthma-susceptible strains numbered 64 and several of these have not previously been associated with asthma. Many of the genes differentially regulated in the susceptible strains were enzymes involved in inflammation. Using network analysis, mRNA for the anti-apoptotic protein survivin was found to be up-regulated in the lungs following allergen challenge. Survivin mRNA and protein were also expressed at high levels in eosinophils recovered by bronchoalveolar lavage from BALB/c and C57BL/6 mice. We propose that rapid apoptosis of lung eosinophils due to low expression of survivin contributes to the limitation of pathology in CBA/Ca mice.
Introduction
Mechanisms that determine why only some members of the population develop asthma have not been fully defined. However, it is generally accepted that in genetically susceptible individuals, inappropriate immune responses to environmental allergens are responsible for the development of disease. Asthma is characterized by reversible obstruction of airflow, excessive mucus production and airway remodelling. Asthmatics often have elevated serum IgE (1) and type 2 cytokines, including IL-4, IL-5 and IL-13, have been implicated in the pathogenesis of disease in both humans and mouse models (2) . The late phase of the asthmatic response to an allergen involves the recruitment and persistence of inflammatory cells such as eosinophils in the lung (3) .
Due to the ready availability of reagents and the capacity for performing experiments under controlled conditions, mouse models are commonly used to dissect the complex pathways involved in the development of asthma. The use of inbred mice also allows the assessment and comparison of populations with identical genetic backgrounds, thus eliminating the variation that exists when investigating outbred populations such as humans. Like humans, the genetic background of different mouse strains can significantly alter the pathogenesis of disease (4) (5) (6) (7) (8) (9) (10) (11) (12) . Mice with the CBA/Ca genetic background mount robust total and ovalbumin (OVA)-specific IgE responses (12) , but unlike the more commonly used BALB/c and C57BL/6 strains, do not develop substantial pathology in the lungs following allergen challenge (3, 11) . When compared with BALB/c and C57BL/6 mice, markedly fewer eosinophils were recovered from the lungs of CBA/Ca animals following allergen challenge and our data suggest that a lung-specific propensity for CBA/Ca eosinophils to undergo apoptosis may be a mechanism by which eosinophil numbers and subsequent pathology are regulated in this strain (11) . Profound eosinophilia induced by over-expression of IL-5 accentuates the inflammatory response and pathology in all three strains, but the extent of disease is still only modest in IL-5 transgenic (Tg) CBA/Ca mice (3, 11, 12) .
To identify novel genes that may affect susceptibility to development of pathology in the lung, we have used microarray gene expression profiling in lung tissue from mice with differing susceptibility to asthma-like disease. We have identified several genes that are differentially regulated in disease-susceptible BALB/c and C57BL/6 mice but not in disease-resistant CBA/Ca mice and further defined the kinetics of expression of these genes. Furthermore, we have shown that survivin is expressed at higher levels in eosinophils recovered from the disease-susceptible strains, compared with asthma-resistant CBA/Ca mice. Lower expression of survivin may therefore inhibit the accumulation of eosinophils at the site of inflammation and limit pathology in the CBA/Ca strain.
Methods

Animals
CBA/Ca, BALB/c and C57BL/6 heterozygous Tg5C2 IL-5 Tg (3, 13) and wild-type (wt) mice were bred under barrier conditions in the University of Adelaide Medical School Animal House. Experimental animals were fed and watered ad libitum and housed in clean conventional conditions under a controlled cycle of 12 h light. All animals were handled according to University of Adelaide Animal Ethics Committee guidelines.
Immunization and challenge
Mice were immunized and challenged as previously described (11) . Briefly, mice were immunized by intraperitoneal injection of 10 lg OVA (Sigma-Aldrich, St Louis, MO, USA) mixed with 1 mg of aluminium hydroxide gel in 50 ll of endotoxin-free (ef) PBS, on each of days 0 and 12. Using a clinical nebulizer, mice were then challenged with aerosols of 1% OVA in efPBS or with efPBS alone, for either 20 min on each of days 28 and 29 (light challenge) or with three 30 min exposures on each of days 22, 24, 26 and 28 (heavy challenge). Mice were euthanized by CO 2 inhalation on day 30 or 32 (light challenge) or day 30 (heavy challenge).
Bronchoalveolar lavage and staining
Bronchoalveolar lavage (BAL) was performed as previously described (11), using three aliquots of 1 ml ice-cold PBS, via a cannula into the trachea. The first 500 ll of cell-free lavage fluid was mixed with 2 ll of proteinase inhibitors (Sigma-Aldrich) and stored at À80°C until analysis for cytokines. Differential cell counts were performed on cytocentrifuged preparations stained with Giemsa (BDH Laboratory Services, Poole, UK). Histology and airways obstruction measurements were performed as previously described (11) .
Preparation and culture of lung-associated lymph node cells Cells were recovered 48 h after heavy allergen challenge and cultured as previously described (11) . Briefly, lungassociated lymph node (LALN) were excised and disaggregated in HBSS. The resulting single-cell suspension was then re-suspended at 1 3 10 6 cells ml À1 in culture medium consisting of RPMI 1640 supplemented with 10% FCS, L-glutamine and penicillin/gentamycin. Two hundred microlitres of cells were cultured with or without 1 mg ml À1 OVA at 37°C in 5% CO 2 in humidified air for 72 h. Supernatant was then stored at À80°C until cytokine analysis.
Recovery and detection of CD3
+ and CD4 + lymphocytes from lung tissue Lung tissue was digested using 1 mg ml À1 collagenase type 1-A (Sigma-Aldrich), 2.5 mM CaCl 2 , 10 mM HEPES and 5% FCS in RPMI 1640 at 37°C for 2 h. Digested tissue was then passed through a 70-lm nylon mesh and washed with PBS. The resulting single-cell suspension was stained with hamster-anti-mouse CD3e (2C11.145) and rat-anti-mouse CD4 (TIB107) mAbs derived from neat hybridoma culture supernatants and the appropriate polyclonal secondary antibodies. Cells defined as lymphocytes using forward and side scatter were analyzed using a FACSCanto flow cytometer and FACS Diva version 5.0.2 software (BD Biosciences, San Jose, CA, USA).
Analysis of cytokines
IL-4, IL-5, IL-10 and IFN-c concentrations were determined in bronchoalveolar lavage fluid (BALF) and LALN cell culture supernatants by ELISA. IL-10 was measured by ELISA (Mabtech, Nacka Strand, Sweden) according to the manufacturer's instructions. IL-4, IL-5 and IFN-c were measured using an in-house ELISA (11) . Monoclonal rat anti-mouse IL-4, IL-5 and IFN-c antibodies were used for capture (11B11, TRFK-5 and R46A2, respectively) and detection (BVD-6, TRFK-4 and AN-18, respectively). The sensitivities of the ELISA systems were 30 pg ml À1 for IL-4, 40 pg ml
À1
for IL-5, 50 pg ml À1 for IL-10 and 30 pg ml À1 for IFN-c.
Microarray analysis
Lung tissue was recovered 72 h after light challenge. Both lungs were placed in 2 ml of Trizol (Ambion, Austin, TX, USA) and homogenized with an Ultra Turrax homogenizer (Janke and Kunkel, Staufen, Germany). RNA was extracted according to the manufacturer's instructions. The integrity and concentration of the RNA was inspected by spectrophotometer and agarose gel electrophoresis. Thirty micrograms of total RNA was reverse transcribed with 4 lg of anchored polyT(V)N and 0.5 lg of random hexamers, 2 ll of 0.1 M dithiothreitol, 2 ll of Moloney murine leukaemia virus reverse transcriptase (200 U ll
À1
, Promega, Madison, WI, USA) and 0.6 ll of aminoallyl (aa) deoxynucleotide triphosphate mix (25 mM deoxyadenosine triphosphate, 25 mM deoxyguanosine triphosphate, 25 mM deoxycytidine triphosphate, 10 mM deoxythymidine triphosphate and 15 mM deoxyuridine triphosphate). Residual RNA was hydrolyzed in 10 ll of 0.25 M NaOH and 10 ll of 0.5 M EDTA (pH 8.0) and reactions were neutralized by adding 15 ll of 0.2 M acetic acid before purification using a QIAquick PCR purification kit (Qiagen, Hilden, Germany). The complementary DNA (cDNA) was coupled to Cy3 or Cy5 (GE Healthcare, Little Chalfont, UK) and re-purified using a QIAquick PCR purification kit (Qiagen). Labelled cDNA was then hybridized to Compugen mouse 22K oligonucleotide microarrays that represented 22,220 mouse genes. A list of all genes on the array can be downloaded from http://www.microarray. adelaide.edu.au/libraries/. Equal amounts of cDNA from individual OVA-challenged mice were competitively hybridized with similarly prepared cDNA from individual PBS-challenged mice on four microarray slides. Dye swaps were performed to limit bias resulting from differential dye incorporation and intensity. Slides were scanned using an Axon 2000B microarray scanner (MDS Analytical Technologies, Concord, Canada).
Signal intensity was extracted using SPOT software (14) and, after background subtraction, was normalized using LIMMA software (15) . Bayesian analysis of the normalized data produced a list of genes that were likely to be consistently differentially expressed. Genes with positive log 2 odds values (B statistic) were selected for functional and gene ontology analysis (16) (17) (18) . Using software available at htpp:// david.abcc.ncifcrf.gov, gene lists were assessed using gene ontology terms (GOTERM_BP/CC/MF_ALL), protein domains (INTERPRO, PIR-super-family and SMART), pathways (BIO-CARTA and KEGG) and functional categories (SP_PIR_KEY-WORDS). Gene networks were identified using Ingenuity Pathways Analysis (Ingenuity Systems, www.ingenuity.com). All normalized gene expression values and data set files are available at www.ncbi.nlm.nih.gov/geo (GSE15429).
Quantitative reverse transcriptase-PCR on lung tissue and BAL eosinophils
The left lung of each mouse was recovered 72 h following cessation of a light allergen challenge and homogenized (as above) and RNA was isolated using a PureLink microto-midi total RNA purification system (Invitrogen, Carlsbad, CA, USA) and treated with DNase (Turbo DNA-free, Ambion). RNA was reverse transcribed using a high capacity cDNA reverse transcriptase kit (Applied Biosystems, Foster City, CA, USA).
To maximize the yield of eosinophils, BAL cells were recovered from IL-5 Tg mice 48 h after cessation of a heavy challenge regime. Eosinophils were sorted to >98% purity, mRNA was recovered and reverse transcribed as previously reported (11) .
Quantitative reverse transcriptase (qRT)-PCR was performed on a Rotor Gene 2000 real-time cycler and analyzed with Rotor Gene version 4.6 software (Corbett Research, Mortlake, Australia) using Power SYBR Green for amplification detection (Applied Biosystems, Warrington, UK). Hydroxymethylbilane synthase and 18s ribosomal RNA were used as controls. Normalized intensity was calculated using qBASE (19) . Intron-spanning primers with melting temperatures between 59 and 61°C were designed using Primer3 (20) manufactured by Geneworks (Adelaide, Australia). Primer sequences, product sizes and accession numbers for each gene are supplied in supplementary Table 1 (available at International Immunology Online). Each product was verified using melting curve analysis and agarose gel electrophoresis.
Detection of survivin by western blot
BAL cells (90-97% eosinophils) were recovered from IL-5 Tg mice 48 h after cessation of a heavy challenge regime. Cells were lysed in Laemmli buffer (21), separated using SDS-PAGE (15% polyacrylamide) and blotted onto nitrocellulose membranes. Membranes were incubated overnight at 4°C with monoclonal anti-human survivin (D-8, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and anti-mouse b-actin (Clone AC-15, Sigma-Aldrich) antibodies and then treated with antimouse IgG-biotinylated secondary antibodies. Antibodies bound to membranes were detected with streptavidin-HRP conjugate and enhanced chemiluminescence (GE Healthcare) and bioluminescence was recorded using Ultra UV-G medical X ray film (AGFA, Morstel, Belgium).
Statistical analysis
Analysis of microarray data is described above. All other statistical analysis was performed using, where appropriate, either one-and two-tailed Student's unpaired t-tests or one-way analysis of variance using the Tukey post-test. A confidence interval of 95% was used for all analyses. Statistical analyses were calculated using GraphPad Prism version 5.0.1 for Windows (GraphPad Software, San Diego, CA, USA).
Results
Morphology and cellular accumulation
Histological analysis of sections of lung tissue recovered from wt mice 72 h after a light OVA aerosol challenge showed strain-dependent variation in the degree of asthmalike pathology (Fig. 1) . After OVA challenge, peribronchial and perivascular inflammatory infiltrates were evident in tissues from BALB/c and C57BL/6 mice and these consisted mostly of eosinophils (Fig. 1B, D and F). Epithelial and goblet cell hyperplasia, airway wall thickening and airway obstruction were evident and comparable in C57BL/6 and BALB/c mice. These disease parameters were all more severe in C57BL/6 and BALB/c mice than in CBA/Ca mice, with the latter showing no airway obstruction (Fig. 1G) . After allergen challenge, significantly more eosinophils, lymphocytes and neutrophils were recovered by BAL of C57BL/6 and BALB/c mice than from CBA/Ca mice ( Fig. 1H-J) . Eosinophils were the dominant subset in all strains (Fig. 1H ). Macrophages were numerous in the lungs of all strains of mice after PBS or OVA challenge (;20-35 3 10 4 cells per mouse) and did not increase significantly in allergenchallenged animals (data not shown).
Lymphocyte function
Since lymphocytes produce cytokines necessary for the development of airway pathology and eosinophil accumulation, these cells were investigated to determine if CBA/Ca mice were resistant to experimental asthma due to defective responses to antigen. Allergen-specific cytokine production by LALN cells was measured 48 h after heavy OVA challenge and production of IL-4 and IL-5, IL-10 and IFN-c was increased by OVA stimulation of cells cultured from all three strains (Fig. 2) . Antigen-specific production of IL-4 and IFN-c was similar for cultures from all three strains ( Fig. 2A and B) . Comparable amounts of IL-5 were detected in cultures from C57BL/6 and CBA/Ca mice, with higher levels produced by cells from BALB/c animals ( Fig. 2C ). Antigen-specific IL-10 production was ;2-and 10-fold higher in LALN cells from C57BL/6 and BALB/c mice, respectively, than in cells from CBA/Ca mice (Fig. 2D ).
BALF cytokines and lung CD4 + cells
Local production of cytokines can influence the degree of allergen-induced lung inflammation. Twenty-four hours after light OVA challenge, IL-4 was significantly increased in BALF from all three strains, but was greatest for BALB/c mice (Fig.  3A) . The production of IL-5 was also increased to a similar degree in all the three mouse strains ( Fig. 3B ) and there was no increase in the amount of IL-10 ( Fig. 3C ). Seventytwo hours after OVA challenge, when both IL-4 and IL-5 had returned to levels comparable to PBS-challenged controls ( Fig. 3D and E), IL-10 production was significantly increased in the asthma-susceptible C57BL/6 and BALB/c strains (Fig.  3F) . No significant up-regulation of IFN-c was observed in any strain at either 24 or 72 h post-challenge (data not shown). The percentage of CD4 + T lymphocytes in whole lung tissue from all three strains increased following OVA challenge, but was greatest in the lungs of BALB/c mice (Fig. 3G) . In BALF, the percentages of CD4 + T lymphocytes post-challenge were 31, 22 and 35% for CBA/Ca, C57BL/6 and BALB/c mice, respectively. Total numbers of BAL CD4 + cells were higher in C57BL/6 and BALB/c mice than in CBA/ Ca animals (;30, 12 and 1.2 3 10 4 , respectively).
Microarray analysis of gene expression
The immune responses and pathology in this model were consistent with a bias towards type 2 cytokine production. Asthma-resistant CBA/Ca mice showed no major aberrations in production of the signature cytokines IL-4, IL-5, IL-10 and IFN-c and so a more global approach was used to identify factors that might explain the large differences in pathology between C57BL/6 and BALB/c mice and the CBA/Ca strain. Microarray transcript profiling of lung tissue was used to identify differential gene regulation and expression networks. We have previously found that the greatest accumulation of inflammatory cells in the lungs in the light challenge model occurs 72 h after the last exposure to OVA aerosols [ (12) and D. J. Tumes and L. A. Dent, unpublished data]. We proposed that initiation of the resolution phase of airway inflammation may be detected at this stage and based on our earlier studies (11) that eosinophil apoptosis could be an important regulator of disease severity. Gene expression analyses were therefore performed on lung tissues from OVAsensitized mice exposed 72 h previously to either OVA or PBS in the light challenge regime. Microarray analysis identified 51, 396 and 249 unique gene sequences as differentially (either up-or down-) regulated in the CBA/Ca, C57BL/6 and BALB/c strains, respectively (Fig. 4) . After further analysis using David software to eliminate redundancies, differentially regulated genes numbered 42, 242 and 145 for CBA/Ca, C57BL/6 and BALB/c strains, respectively. Genes of potential interest that met the selection criteria for differential expression are listed in Table 1 and a full list of differentially regulated genes are available in supplementary Table 2 (available at International Immunology Online). While C57BL/6 and BALB/c mice develop similar levels of pathology following allergen challenge, the mechanisms that contribute to disease may vary (4, 5, 9, 12) . David software was used to analyse up-regulated genes for ontology groups that were over-represented in each strain. A striking feature was the large proportion of genes up-regulated in BALB/c and C57BL/6 mice that encoded antibody proteins and especially those for variable Ig domain (v-set) proteins (INTERPRO database for v-set: 34 genes at P = 2.4 3 10 À25 and 19 genes at P = 1.5 3 10
À5
, respectively). In comparison, up-regulation of variable Ig genes was very limited in lungs from CBA/Ca mice (three genes, at P = 0.28). One of the most significantly enriched ontogeny groups in C57BL/6 mice contained genes for cell adhesion molecules (GOTERM_BP_ALL database: 23 genes at P = 0.001; four genes at P = 0.46 and five genes at P = 0.072 for C57BL/6, BALB/c and CBA/Ca mice, respectively). In C57BL/6 mice, genes in this group include those coding for CD162 [P-selectin glycoprotein ligand-1 (PSGL-1)] and the b2 and b7 integrins, all of which are expressed on endothelial cells and/or leukocytes.
Several genes were highly up-regulated in all three strains (Table 1) . These included eosinophil-associated ribonuclease A (Ear) family members Ear3 and Ear5, chemokine (c-c motif) ligand (Ccl) 8, Ccl9 and Ccl24, chloride channel calcium activated 3 (Clca3), solute carrier family 26, member 4 (Slc26a4), resistin-like alpha (Retnla, formerly named Fizz1), chitinase 3-like 3 (Chi3l3, formerly named Ym1) and macrophage galactose N-acetyl-galactosamine specific lectin 1 (Mgl1). Up-regulation of the Ear genes is consistent with the relatively large number of eosinophils found in the lungs of all three strains after allergen challenge. It also suggests that eosinophils recruited to the allergic lung were synthesizing new granule proteins. mRNA for the eosinophil-specific chemokine CCL11 (eotaxin-1) is up-regulated in allergic lungs from all three strains (12) and although supported by this microarray analysis, only samples from C57BL/6 mice met the B statistic selection criterion. In contrast, changes in the expression of the genes encoding CCL8, 9 and 24 did meet all selection criteria and these are chemokines not previously associated with eosinophil chemotaxis.
In addition to assessing responses to allergen within strains, our analyses also enabled comparisons of the two asthma-susceptible strains with resistant CBA/Ca mice. Following OVA challenge, 64 genes were differentially regulated in both the susceptible strains, but not in CBA/Ca mice. Within this group, 44 genes (69%) were up-regulated and those previously associated with asthma include matrix metalloelastase 12 (Mmp12) (22) , secretory leukocyte peptidase inhibitor (Slpi) (23), serine peptidase inhibitor clade A member 3N (Serpina3n) (24, 25) , cathepsin S (Ctss) (26), lipocalin (Lcn2) (27) , S100 calcium binding protein A4 (S100a4) (24), Arginase 1 (Arg1) (28) and chitinase 3-like 1 (Chi3l1) (29) . Up-regulated genes in this group that had not been previously associated with asthma include IFN-c-inducible protein 30 (Ifi30), Hippocalcin (Hpca), Sec 24 related gene family, member A (Sec24a) and the transcription factors E74-like factor 2 (Elf2) and ELL-associated factor 2 (Eaf2). The largely uncharacterized genes, 2010001M09Rik and 
CD4
+ T lymphocytes recovered from whole lung digests 72 h after light allergen challenge, n = 4-6 mice per group. Data expressed as mean + SEM, #P < 0.05 indicates OVA-challenged BALB/c > OVA-challenged CBA/Ca and C57BL/6, *P < 0.05 indicates significantly greater than respective PBS-challenged control groups. 4933401D09Rik, were also up-regulated. Of the 24 genes that were down-regulated only in the susceptible strains, a high proportion (46%) encode enzymes that include guanylate cyclase1 soluble alpha 3 (Gucy1a3), tryptophan hydroxylase 1 (Tph1), indolethylamine N-methyltransferase (Inmt), paraoxonase 1 (Pon1) and hydroxyprostaglandin dehydrogenase (Hpgd) 15 .
A relatively small group of 16 genes was differentially regulated only in the resistant CBA/Ca mice and we hypothesized that a factor present in the lungs of these mice may confer protection against disease. Up-regulated genes of potential significance in this group include those coding for mannose receptor C type 1(Mrc1) and Lplunk1 (U46068). L-selectin (Sell), glycosylation-dependent cell adhesion molecule 1 (Glycam1) and CCL21 (Ccl21) are involved in cell recruitment, and expression of these genes was downregulated only in the resistant CBA/Ca strain.
qRT-PCR analysis of genes selected from microarray profiles
qRT-PCR was performed to confirm data from the microarray analysis and to further investigate the expression kinetics of genes of interest. In the microarray analysis of lung tissues recovered 72 h after allergen exposure, Chi3l3 and Retnla were highly up-regulated in C57BL/6 and BALB/c mice, with a smaller but significant up-regulation in the CBA/Ca strain. In contrast, Mmp12 and 2010001M09Rik were up-regulated only in the susceptible strains. Using qRT-PCR, there was little or no up-regulation of Chi3l3 or Retnla 24 h after allergen challenge ( Fig. 5A and C) ; however, both these genes were markedly up-regulated at 72 h, with 3-, 7-and 10-fold changes for Chi3l3 and 35-, 75-and 100-fold changes for Retnla in CBA/Ca, C57BL/6 and BALB/c mice, respectively ( Fig. 5B and D) . The expression of Mmp12 followed a similar pattern (Fig. 5E and F) , with only small increases evident 24 h post-challenge in all the three strains (Fig. 5E ) and a more marked increases at 72 h (Fig. 5F ). This increase in Mmp12 expression was significantly greater in the disease-susceptible strains (up-regulated 5-, 13-and 17-fold in CBA/Ca, C57BL/6 and BALB/c mice, respectively). Expression of 2010001M09Rik was unaltered 24 h after allergen exposure (Fig. 6G ), but by 72 h a marked increase in mRNA was detected and this was greatest in lung tissue from the disease-susceptible C57BL/6 and BALB/c strains (;2-fold for CBA/Ca and 3-to 4-fold for C57BL/6 and BALB/c, Fig. 6H ). The degree of up-regulation measured by qRT-PCR was generally higher than that indicated by microarrays, but the two data sets were mostly consistent. Of 18 genes significantly up-or down-regulated in the microarray analysis, 16 were found to be similarly modulated when assessed by qRT-PCR (Table 2) .
Gene network analysis
Biological associations of genes differentially regulated in the disease-susceptible strains were modelled using Ingenuity Pathways Analysis. Strong associations were found between survivin (Birc5) and several genes differentially regulated only in the asthma-susceptible strains. The microarray data suggested that survivin mRNA was up-regulated 1.1-, 1.7-and 1.4-fold for CBA/Ca, C57BL/6 and BALB/c, respectively. While the majority of these data did not meet initial selection criteria, survivin expression was explored on the basis of the promising network analysis and potential links to leukocyte apoptosis. qRT-PCR analysis of survivin gene expression in lung tissue demonstrated significant upregulation in all the three strains at both 24 ( Fig. 5I ) and 72 h (Fig. 5J) post-challenge. In contrast to the other genes represented in Fig. 5 , the greatest up-regulation of survivin mRNA occurred 24 h post-challenge, with 4.8-, 5.2-and 10.4-fold changes detected for CBA/Ca, C57BL/6 and BALB/c mice, respectively. Levels of survivin expression in lung tissue were highest in the asthma-susceptible BALB/c strain at both 24 and 72 h post-challenge and at the latter time point, this was significantly greater than in CBA/Ca mice.
Survivin expression in BAL eosinophils
Less eosinophils accumulate in the lungs of CBA/Ca mice than in C57BL/6 and BALB/c mice after OVA immunization and challenge. Furthermore, we have previously shown that BAL eosinophils recovered from the lungs of CBA/Ca mice display an increased propensity to undergo apoptosis (11) . IL-3, IL-5 and granulocyte macrophage colony-stimulating factor (GM-CSF) can modulate the expression of survivin in eosinophils in vitro (30) and since survivin mRNA expression in the lungs was increased after allergen exposure, the expression of this molecule was assessed in BAL eosinophils. In order to recover sufficient BAL eosinophils from the lungs of OVA-immunized and -challenged CBA/Ca mice, animals over-expressing IL-5 were used for this experiment. We have previously shown that the relative susceptibility to pathology and propensity of eosinophils to undergo apoptosis are maintained when the IL-5 transgene is expressed across the three strains (11) . Survivin mRNA was detected in BAL eosinophils (>98% purity) from OVA-immunized and -challenged IL-5 Tg mice on all three genetic backgrounds. C57BL/6 and BALB/c eosinophils expressed 3-and 20-fold more survivin mRNA, respectively, than eosinophils from CBA/Ca donors (Fig. 6A) . Survivin protein expression in BAL eosinophils (90-97% purity) was also highest in the C57BL/6 and BALB/c mice (Fig. 6B) .
Discussion
The principal aim of this study was to explore mechanisms that might explain differences in leukocyte recruitment and pathology in two asthma-susceptible strains (C57BL/6 and BALB/c) and in the asthma-resistant CBA/Ca strain. C57BL/ 6 and BALB/c mice developed significant lung pathology in response to immunization and light challenge with aerosols of OVA. This included elevated mucus secretion that contributed to occlusion of airways and eosinophil-rich leukocyte infiltration of perivascular and peribronchiolar tissues. In contrast, pathology was very limited in the CBA/Ca strain. All three strains developed both type 1 and 2 cytokine responses, with IL-4 and IL-5 production being greatest in allergic BALB/c mice. IL-10 production from LALN cells and/or in BALF increased in all three strains after allergen challenge and again levels were highest for BALB/c donors. Microarray gene expression analysis of lung tissue collected at the point of maximum leukocyte accumulation after allergen challenge identified the C57BL/6 and BALB/c strains as those with the highest number of differentially regulated genes (5-8 times more genes than in the CBA/Ca strain). Genes up-regulated in the asthma-susceptible strains included a number previously reported to be associated with inflammation of the airways, including Chi3l3, Retlna and Mmp12. Several other up-regulated genes, including 2010001M09Rik and survivin have not previously been reported to be associated with this disease. The strong accumulation of eosinophils in the lungs of the asthmasusceptible strains was associated with higher levels of expression of the survivin gene in both lung tissue and BAL eosinophils. Survivin protein levels were also at highest levels in BAL eosinophils from the asthma-susceptible strains. Our data suggest that cell adhesion molecules involved in leukocyte recruitment and survivin may be key factors in the accumulation and persistence of eosinophils in the allergic lung. As a consequence, these may contribute to pathology in the allergic airways response.
Using a light OVA immunization and challenge regime in wt mice, we have confirmed our earlier findings that CBA/Ca mice are far less susceptible to the development of asthma-like inflammation than BALB/c and C57BL/6 mice (11, 12) . Our earlier studies suggest that less inflammatory cells accumulate in the lungs of CBA/Ca mice because eosinophils recruited to the lungs are more prone to apoptosis than eosinophils recovered from the lungs of allergic C57BL/6 and BALB/c mice and that the increased viability of BALB/c BAL eosinophils may be due to increased expression of IL-5 and the pro-apoptotic proteins Bcl-2 and Bclx L (11) . In addition, eosinophil recruitment to the lungs may be more efficient at least in the C57BL/6 strain (12), a conclusion supported by the current microarray analysis. There is no obvious defect in the ex vivo lifespan of lymphocytes recruited to the lungs of CBA/Ca mice (11) . In this study, we have shown that there were many more CD4 + T cells in the lungs and BALF of the asthma-susceptible strains than in allergic CBA/Ca mice. Nevertheless, for all strains both type 1 and 2 cytokines were produced in situ in the lungs and/or after antigen stimulation of LALN cell cultures. Overall, BALB/c mice had the highest levels of type 2 cytokines and IL-10 in the lungs and/or in cultures of LALN cells, in keeping with it being a prototypical type 2 cytokine-biased strain.
After OVA challenge, lung tissue from C57BL/6 mice showed increased expression of a number of genes encoding cellular adhesion molecules, including CD162 (PSGL-1), which binds to P, E and L-selectin (31), CD18 (b2 integrin), which forms heterodimers with CD11a, b and c and binds to intercellular adhesion molecules-1, -2, -3 and -4 (32) and b7 integrin, which heterodimerizes with CD49d (a4 integrin) to form lymphocyte Peyer's patch adhesion molecule-1 (LPAM-1), a ligand for mucosal addressin cell adhesion molecule-1, vascular cell adhesion molecule-1 and fibronectin (33, 34) . PSGL-1, CD18 and LPAM-1 all affect eosinophil accumulation (34) (35) (36) . We have recently shown that BAL eosinophils recovered from C57BL/6 mice express higher amounts of L-selectin mRNA when compared with BALB/c and CBA/Ca mice (12) . While little L-selectin gene expression was detected in lung tissue from C57BL/6 or BALB/c mice using microarray analysis, mRNA encoding L-selectin and its endothelial ligand, GLYCAM-1 were significantly down-regulated in CBA/Ca mice following allergen challenge. It is therefore possible that in allergic CBA/Ca mice, active inhibition of inflammatory cell accumulation may in part be occurring via this mechanism.
Following allergen challenge, several genes associated with asthma in other microarray studies were shown to be up-regulated in both the susceptible strains (C57BL/6 and BALB/c), but not in resistant CBA/Ca mice. In addition, we report for the first time several genes up-regulated in only the susceptible strains that have not previously been associated with asthma or asthma-like inflammation. These include Ifi30, the gene for gamma interferon-inducible thiol reductase (GLIT), which is involved in the late endosomal compartment during the processing and presentation of exogenous antigen (37) and in inhibition T cell activation (38) . While there appears to be no deficiency in the ability of the CBA/Ca immune system to mount a response to OVA in the periphery (12) , tight regulation of localized antigen processing and presentation may occur in the lungs of CBA/Ca mice. Two largely uncharacterized genes, 2010001M09Rik and 4933401D09Rik, were up-regulated only in the susceptible strains. Differential regulation of 2010001M09Rik was not detected until 72 h after allergen challenge, indicating that this gene may be involved in resolution of the inflammatory process. While 2010001M09Rik has 62% homology with the human pro-apoptotic caspase adaptor protein gene (39) , it may yet prove to have an antiapopototic role. The function of 4933401D09Rik is unknown. Further studies are required to determine which cells express these genes and what roles the products play in inflammatory lung disease.
Genes encoding enzymes represented a large proportion of those down-regulated in only the susceptible strains and several of these, including Gucy1a3, Pon1, Tph1 and Hpgd, may be involved in modulating asthma symptoms. Gucy1a3 is a member of the soluble guanylate cyclase (sGC) family of genes, the products of which can contribute to smooth muscle relaxation. sGC is down-regulated in a similar model of allergic asthma and airways hyperreactivity is increased if it is inhibited (40) . Paraoxonase-1 has anti-oxidant properties and expression of Pon1 is enhanced in a hepatoma cell line and in vivo in LPS treated mice following dexamethasone treatment (41). Tph1 encodes an essential enzyme for the production of serotonin (42) . Although serotonin is better known as a neurotransmitter in the central nervous system, it has recently been shown to increase the expression of IL-10 and prostaglandin E2 (PG)E 2 by alveolar macrophages (43) and both these molecules may have anti-inflammatory effects in asthma. Suppression of these genes in the susceptible strains may promote inflammation and tissue damage. Conversely, transcriptional down-regulation of Hpgd, the gene encoding 15 hydroxyprostaglandin dehydrogenase (PGDH) may contribute to resolution of asthma. PGDH is able to metabolize prostaglandin (PG)E 2 to 15-keto-PGE 2 and ablation of Hpgd in mice increases accumulation of PGE 2 in the lung and as a consequence protects against bronchoconstriction (44). PGE 2 may also limit pathology by inhibiting eosinophil accumulation in the lungs (45) .
Retnla, Chi3l3 and Mgl1 are markedly up-regulated in the lungs 72 h after allergen challenge, indicating involvement in the late phase of the allergic response. These genes are highly expressed in alternatively activated macrophages (AAMs) and have been used as markers of this cell type (46, 47) . Alveolar macrophages have previously been shown to decrease pulmonary inflammation (48) and are capable of modulating asthma (49) . IL-10 production by alveolar macrophages is associated with resistance to development of pathology in rodent models of allergic asthma (50, 51) and adenoviral over-expression of IL-10 in the lung reduces inflammation in a murine model of asthma (52) . In our study, IL-10 protein was significantly elevated 72 h after allergen exposure in C57BL/6 and BALB/c mice and through this mechanism AAM may be contributing to the resolution of inflammation in strains where disease is most severe.
Eosinophils are recruited from the peripheral blood into the lungs of allergic CBA/Ca mice, but fail to accumulate to the same extent as in the asthma-susceptible strains (12) . BAL eosinophils from the CBA/Ca strain also more readily undergo apoptosis than eosinophils from the other strains (11) . Survivin is highly expressed in most types of cancer, deregulating cell cycle progression and preventing apoptosis (53) . Survivin also regulates the maturation and function of cells of the immune system (30, 54, 55) . In neutrophils, survivin is necessary for the lifespan-prolonging effects of GM-CSF and granulocyte CSF (55) . Survivin is upregulated in eosinophils by exposure in vitro to IL-3, IL-5 and GM-CSF and immunodepletion of survivin from cell-free extracts of eosinophils from idiopathic hypereosinophilic syndrome patients results in increased cytochrome c dependent caspase 3 cleavage (30) . These studies suggest that survivin can also control the apoptosis of granulocytes. Although not initially detected using our microarray screening criteria, survivin was identified as a gene of interest using genetic network analysis. Higher level analysis of microarray data using gene networks has therefore assisted in identifying a gene not previously associated with eosinophils in asthma. We propose that survivin may also control the lifespan of eosinophils in the allergic lung. Survivin mRNA expression was upregulated in lung tissue after allergen challenge in all three strains, but BAL eosinophils from the disease-susceptible C57BL/6 and BALB/c strains expressed the highest levels of survivin mRNA and protein. Expression of survivin and the related protein cellular inhibitor of apoptosis protein-2 are elevated in eosinophils recovered from the blood of patients with hyper-eosinophilic syndrome (30) , suggesting that survivin may be important in other eosinophil-associated diseases where eosinophil accumulation can contribute to pathology. This study identifies several genes associated with susceptibility or resistance to development of experimental asthma. Furthermore, we suggest that differential expression of survivin may regulate the lifespan of eosinophils in the inflamed lung and may provide a new target for the design of anti-inflammatory drugs.
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